Table 2. Baseline and selected characteristics of study patients by IV tPA administration.
IV tPA: intravenous tissue plasminogen activator; TICI: Thrombolysis in Cerebral Infarction score; MCA: middle cerebral artery.
| Table 2. Baseline and selected characteristics of study patients by IV tPA administration | |||||
| Variable | Total N=178 | no tPA n=81 | tPA n=76 | P-value | |
| Gender, n (%) | 0.19 | ||||
| Male | 87 (55.4) | 49 (60.5) | 38 (50.0) | ||
| Female | 70 (44.6) | 32 (39.5) | 38 (50.0) | ||
| Race, n (%) | 0.50 | ||||
| White | 95 (64.2) | 51 (65.4) | 44 (62.9) | ||
| Black | 51 (34.5) | 25 (32.0) | 26 (37.1) | ||
| Asian | 2 (1.3) | 2 (2.6) | 0 (0.0) | ||
| Hemicraniectomy, n (%) | 4 (2.6) | 1 (1.2) | 3 (4.0) | 0.36 | |
| TICI score, n (%) | 0.26 | ||||
| grade 0 | 14 (8.9) | 6 (7.4) | 8 (10.5) | ||
| grade 1 | 7 (4.5) | 1 (1.2) | 6 (7.9) | ||
| grade 2a | 23 (14.6) | 11 (13.6) | 12 (15.8) | ||
| grade 2b | 53 (33.8) | 30 (37.1) | 23 (30.3) | ||
| grade 3 | 60 (38.2) | 33 (40.7) | 27 (35.5) | ||
| Fraction of MCA territory | |||||
| infarcted, n (%) | 0.85 | ||||
| < 1/3 | 60 (38.7) | 32 (40.5) | 28 (36.8) | ||
| between 1/3 and 2/3 | 45 (29.0) | 23 (29.1) | 22 (29.0) | ||
| > 2/3 | 50 (32.3) | 24 (30.4) | 26 (34.2) | ||
| Stroke side | 0.07 | ||||
| Left | 81 (53.3) | 46 (60.5) | 35 (46.1) | ||
| Right | 71 (46.7) | 30 (39.5) | 41 (53.9) | ||
| Smoking, n (%) | 84 (56.0) | 49 (62.8) | 35 (48.6) | 0.08 | |
| Atrial fibrillation, n (%) | 31 (19.8) | 17 (21.0) | 14 (18.4) | 0.69 | |
| Diabetes mellitus, n (%) | 28 (17.8) | 14 (17.3) | 14 (18.4) | 0.85 | |
| Hypertension, n (%) | 87 (55.4) | 39 (48.2) | 48 (63.2) | 0.06 | |
| Hyperlipedemia, n (%) | 45 (28.7) | 20 (24.7) | 25 (32.9) | 0.26 | |
| Coronary artery disease, n (%) | 15 (9.6) | 6 (7.4) | 9 (11.8) | 0.35 | |
| *p<0.05 statistically significant | |||||